Leading Oncologist for Gastro-intestinal Cancer
Position: Head of the Gastro-intestinal Malignancy Service in Oncology Department
Hospital: Assuta Medical Center, Tel Aviv.
Dr. Esther Tahover is in the Forbes magazine’s list of the best doctors in Israel
Qualified Medical Consultation Online, Second Opinion
Private Medical Consultation and Second Opinion for Gastro-intestinal Cancer
- Early and Metastatic stages of Gastro-intestinal Cancer
- Colorectal Cancer
- Stomach (Gastric) Cancer
- Esophageal Cancer
- Pancreatic Cancer
- Liver Cancer
- Gallbladder Cancer
- Small Intestine Cancer
- Rectal Cancer
- Gastrointestinal Stromal Tumors (GIST)
- Neuroendocrine Tumors (NETs)
Send Your Medical Files Book Consultation Now
Professional Experience of Dr. Esther Tahover
- 2008-2013 Oncology Department, Sharett Institute, Hadassah Medical Center, Jerusalem
- 2022-present Head of the Gastro-intestinal Malignancy Service, Oncology Department, Assuta Medical Center, Ramat HaHayal
- 2020-2022 Head of the Gastro-intestinal Malignancy Service, Oncology Department, Shaare Zedek Medical Center, Jerusalem
- 2013-2020 Senior Physician, Oncology Department, Shaare Zedek Medical Center, Jerusalem
- 2015-2021 Instructor, Medicine, Hebrew University-Hadassah Medical School, Jerusalem
Education of Dr.Tahover
- 1999-2002 BMedSc: Hebrew University-Hadassah Medical School, Jerusalem
- 2002-2006 Graduated as Doctor of Medicine: Hebrew University-Hadassah Medical School, Jerusalem
- 2006-2007 Intern: Hadassah Medical Center, Jerusalem
- 2013 Board certification in medical oncology
- 2015-2016 PhD candidate in Genomics and bioinformatics: Bar Ilan University, Ramat Gan
- 2022-present Lecturer, Medicine, Hebrew University-Hadassah Medical School, Jerusalem
- Responsible for teaching medical students in oncology at the National Academy of Sciences since 2013
Professional Associations
- Medical Innovation & Entrepreneurship fellow: Israel Medical Association and the Israeli Society for Health Technology
- Gastrointestinal group in the Israel Society of Clinical Oncology and Radiation Therapy
- Israel Society of Clinical Oncology and Radiation Therapy
- European Society of Medical Oncology (ESMO)
- American Society of Clinical Oncology (ASCO)
- Colon Cancer Association
Scientific Research and Treatment Discoveries
Dr. Esther Tahover published dozens of articles in international and Israeli peer-reviewed journals and conference proceedings. Also, she lectured in numerous national and international conferences.
Among her last publications are studies such as:
- Dexrazoxane added to doxorubicin-based adjuvant chemotherapy of breast cancer – To assess whether adding dexrazoxane to doxorubicin-based adjuvant therapy increases bone marrow suppression in breast cancer patients.
- Anemia as a predictor of colorectal cancer prognosis in the pre-operative stage – To determine if anemia can predict the prognosis of colorectal cancer (CRC) in the pre-operative stage. The study also analyzed the correlation between anemia and the stage of CRC at diagnosis.
- Bevacizumab and chemotherapy in metastatic colorectal cancer patients – the safety and efficacy of bevacizumab combined with chemotherapy in patients with metastatic colorectal cancer (mCRC), particularly focusing on differences between patients aged 70 and older versus those younger than 70
- and more
More publications of Dr. Esther Tahover: https://pubmed.ncbi.nlm.nih.gov/
